지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2013.9
- 수록면
- 164 - 169 (6page)
이용수
이 논문의 연구 히스토리 (2)
- 이 논문의 후속연구가 궁금하신가요?
- 연관 학술논문 또는 학술발표를 통해 보다 발전된 연구결과를 확인하실 수 있습니다.
- 이 논문의 연구 히스토리 확인하기
초록· 키워드
오류제보하기
Objectives：We assessed the availability of Aberrant Behavior Checklist (ABC) for the evaluation of the pharmacological effect in autistic disorder.
Methods：A retrospective review of the medical records of 27 children with autistic disorder, who visited the department of child and adolescent psychiatry of Kyungpook National University Hospital, from October 2011 to February 2013, was conducted. After treatment with risperidone, changes in the severity and improvement of symptoms were measured using ABC at the baseline, 2nd visit and 3rd visit, respectively.
Results：The mean daily dose of risperidone increased from 0.66±0.27mg (baseline, initial dose) to 1.02±0.50mg, 2nd visit, and 1.19±0.50mg, 3rd visit. According to ABC, irritability, lethargy, hyperactivity, and inappropriate speech subscale scores decreased significantly from the baseline to 2nd visit. Irritability and Hyperactivity subscale scores decreased significantly from the 2nd to 3rd visit. All subscales and total scores of ABC decreased significantly from the baseline to 3rd visit.
Conclusion：The results of this study suggest that ABC can be used as an efficient tool to measure the symptoms of autistic disorder and to evaluate the medication effect on continuous treatment.
Methods：A retrospective review of the medical records of 27 children with autistic disorder, who visited the department of child and adolescent psychiatry of Kyungpook National University Hospital, from October 2011 to February 2013, was conducted. After treatment with risperidone, changes in the severity and improvement of symptoms were measured using ABC at the baseline, 2nd visit and 3rd visit, respectively.
Results：The mean daily dose of risperidone increased from 0.66±0.27mg (baseline, initial dose) to 1.02±0.50mg, 2nd visit, and 1.19±0.50mg, 3rd visit. According to ABC, irritability, lethargy, hyperactivity, and inappropriate speech subscale scores decreased significantly from the baseline to 2nd visit. Irritability and Hyperactivity subscale scores decreased significantly from the 2nd to 3rd visit. All subscales and total scores of ABC decreased significantly from the baseline to 3rd visit.
Conclusion：The results of this study suggest that ABC can be used as an efficient tool to measure the symptoms of autistic disorder and to evaluate the medication effect on continuous treatment.
목차
서론
방법
결과
고찰
결론
References
참고문헌 (2)
참고문헌 신청
이 논문의 저자 정보
이 논문과 함께 이용한 논문
자폐 스펙트럼 장애 청소년에서 주의력결핍 과잉행동장애 유무에 따른 임상적 특성 : 자폐증상, 정서문제, 부모·자녀관계를 중심으로
송재원
,
반건호
,
조인희
외 7명
소아청소년정신의학
2013
.12
자폐 스펙트럼장애의 환경 요인
임명호
,
권호장
소아청소년정신의학
2011
.03
자폐스펙트럼장애 진단에서 Child Behavior Checklist 1.5-5 유아 행동평가척도 부모용의 변별력
이선희
,
하은혜
,
송동호
소아청소년정신의학
2015
.03
자폐스펙트럼장애 환자에서 나타나는 운동 상동증 유무에 따른 임상 특성의 차이
김지순
,
유희정
,
배정훈
외 11명
소아청소년정신의학
2015
.03
소아정신의학 역사 속의 진단기준 발전과 현상학적 기술정신의학
반건호
,
이연정
,
한주희
소아청소년정신의학
2015
.03
최근 본 자료
댓글(0)
0